BBBen Bridgewater

Ben Bridgewater

*This is an algorithmically generated author record based on publicly available information.

Ben Bridgewater has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Stuart W. Grant

    Department of Cardiothoracic Surgery , Manchester Academic Health Science Centre, University of Manchester, University Hospital of South Manchester , Manchester , UK b National Institute for Cardiovascular Outcomes Research (NICOR) , University College London, London , UK

    7 shared publications
  • Graeme L. Hickey

    National Institute for Cardiovascular Outcomes Research (NICOR) , University College London, London , UK c Department of Epidemiology and Population Health , Institute of Infection and Global Health, University of Liverpool, The Farr Institute @ HeRC , Liverpool , UK

    6 shared publications
  • Graeme L Hickey

    Centre for Health Informatics, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK National Institute for Cardiovascular Outcomes Research (NICOR), University College London, London W1T 7HA, UK

    3 shared publications
  • Graham Cooper

    Department of Cardiothoracic Surgery , Northern General Hospital , Sheffield , UK

    3 shared publications
  • Iain Buchan

    University of Liverpool

    3 shared publications
  • Ioannis Dimarakis

    Department of Cardiothoracic Surgery, Manchester Academic Health Science Centre, University of Manchester, University Hospital of South Manchester Manchester, UK

    3 shared publications

Latest Publications

  • Open Access

    Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantation

    by Stuart W. Grant, Graeme L. Hickey, Peter Ludman, Neil Moat, David Cunningham, Mark de Belder, Daniel J. Blackman, David Hildick-Smith, Rakesh Uppal, Simon Kendall, et al.

    The first transcatheter aortic valve implantation (TAVI) in England and Wales was performed in 2007. This study presents the subsequent national activity and outcomes for both TAVI and aortic valve replacement (AVR). Data for all AVR and TAVI procedures between January 2006 and December 2012 in England and Wales were included. The number of procedures, patient characteristics, in-hospital and 30-day mortality, postoperative length of stay (PLOS) and survival were analysed separately for: isolated AVR; AVR + coronary artery bypass graft (CABG) surgery; AVR + other surgery and TAVI. The number of TAVIs increased from 66 in 2007 (0.8% of all implants) to 1186 in 2012 (10.9% of all implants). AVR activity also increased over the study period. TAVI patients were older and had a higher mean logistic EuroSCORE than all AVR groups. The 30-day mortality rates were 2.1% for isolated AVR, 3.9% for AVR + CABG, 7.7% for AVR + other surgery and 6.2% for TAVI. In-hospital mortality has significantly improved for all groups. The 5-year survival rates were 82.6% for isolated AVR, 81.7% for AVR + CABG, 74.5% for AVR + other surgery and 46.1% for TAVI. The median PLOS after TAVI was similar to that of isolated AVR but shorter than that of the other AVR groups. Since the introduction of TAVI, there has been an increase in both TAVI and AVR activity. TAVIs now represent over 10% of all aortic valve implants. There are distinct differences between procedural groups with respect to patient risk factors. Outcomes for all procedural groups have improved, but long-term TAVI results are required before its role in the treatment of aortic stenosis can be fully defined.


  • Impact of Hepatic Cirrhosis on Outcome in Adult Cardiac Surgery

    by Stuart Grant, Rebecca Corless, Theodore Velissaris, Martin Prince, Ben Bridgewater, George Asimakopoulos, Ioannis Dimarakis

    Increasing prevalence of hepatic disease is likely to translate in a growing number of patients with significant hepatic disease requiring cardiac surgery. Available cardiac risk stratification models do not address the risk associated with hepatic disease. However, weighted mean mortality rates based on previous studies of cardiac surgery in patients with hepatic disease demonstrate operative mortality rates that range from 9.88% (standard deviation [SD] 9.69) for patients in Child–Turcotte–Pugh (CTP) class A cirrhosis to 69.23% (SD 28.55) for patients with CTP class C cirrhosis. This review comprehensively appraises the pathophysiology of hepatic disease, reported clinical outcomes and considerations for risk stratification.


  • Open Access

    Surgeon length of service and risk-adjusted outcomes: linked observational analysis of the UK National Adult Cardiac Surgery Audit Registry and General Medical Council Register

    by Graeme L Hickey, Stuart W Grant, Nick Freemantle, David Cunningham, Christopher M Munsch, Steven A Livesey, James Roxburgh, Iain Buchan, Ben Bridgewater

    To explore the relationship between in-hospital mortality following adult cardiac surgery and the time since primary clinical qualification for the responsible consultant cardiac surgeon (a proxy for experience). Retrospective analysis of prospectively collected national registry data over a 10-year period using mixed-effects multiple logistic regression modelling. Surgeon experience was defined as the time between the date of surgery and award of primary clinical qualification. UK National Health Service hospitals performing cardiac surgery between January 2003 and December 2012. All patients undergoing coronary artery bypass grafts and/or valve surgery under the care of a consultant cardiac surgeon. All-cause in-hospital mortality. A total of 292,973 operations performed by 273 consultant surgeons (with lengths of service from 11.2 to 42.0 years) were included. Crude mortality increased approximately linearly until 33 years service, before decreasing. After adjusting for case-mix and year of surgery, there remained a statistically significant (p = 0.002) association between length of service and in-hospital mortality (odds ratio 1.013; 95% CI 1.005–1.021 for each year of ‘experience’). Consultant cardiac surgeons take on increasingly complex surgery as they gain experience. With this progression, the incidence of adverse outcomes is expected to increase, as is demonstrated in this study. After adjusting for case-mix using the EuroSCORE, we observed an increased risk of mortality in patients operated on by longer serving surgeons. This finding may reflect under-adjustment for risk, unmeasured confounding or a real association. Further research into outcomes over the time course of surgeon's careers is required.


  • Mitral valve prosthesis choice for patients aged 65 years and over in the UK. Are the guidelines being followed and does it matter?

    by Ioannis Dimarakis, Stuart W Grant, Graeme L Hickey, Ramesh Patel, Steve Livesey, Neil Moat, Frank Wells, Ben Bridgewater

    Objective Current guidelines recommend that most patients aged ≥65 years should undergo mitral valve replacement (MVR) using a biological prosthesis. The objectives of this study were to assess whether these guidelines are being followed in UK practice, and to investigate whether the guidelines are appropriate based on in-hospital mortality and mid-term survival. Methods Data from the National Institute for Cardiovascular Outcomes Research Adult Cardiac Surgery Audit database from all National Health Service (NHS) hospitals and some private hospitals performing adult cardiac surgery in the UK between April 2001 and March 2011 were analysed. The overall cohort included 3862 patients aged ≥65 years who underwent first-time MVR. Propensity score matching and regression adjustment were used to compare outcomes between prosthesis groups. Results The mean age was 73.0 years (SD 4.9) with 50% of patients having surgery with a mechanical prosthesis. This proportion decreased over the study period and with increasing patient age with marked variation between hospitals. In the propensity-matched cohort, in-hospital mortality in the biological group was 6.9%, and in the mechanical group it was 5.9% giving an unadjusted OR of 1.17 (95% CI 0.84 to 1.63). There was no significant difference in mid-term survival between the matched groups with an unadjusted HR for biological prosthesis of 1.08 (95% CI 0.93 to 1.24). Similar results were found when using regression adjustment on unmatched data. Conclusions Current guidelines concerning age and mitral valve prosthesis choice are not being followed for patients aged ≥65 years. With regards to in-hospital and mid-term mortality, this study demonstrates that there is no difference between prosthesis types.


  • Open Access

    A technical review of the United Kingdom National Adult Cardiac Surgery Governance Analysis 2008–11

    by Graeme L. Hickey, Rebecca Cosgriff, Stuart W. Grant, Graham Cooper, John Deanfield, James Roxburgh, Ben Bridgewater

    The Society for Cardiothoracic Surgery in Great Britain and Ireland (SCTS) has published named mortality data since 2001. The importance of accurate and robust clinical outcome reporting has been emphasized by a number of high-profile cases in England. In this article, we give a technical review of the United Kingdom National Adult Cardiac Surgery Governance Analysis 2008–11. The statistical and analytical assumptions and methods are discussed in order to add an additional layer of transparency to the clinical governance process and precipitate scrutiny with the aim of optimizing future analyses.


  • Open Access

    Almanac 2012 adult cardiac surgery

    by Ben Bridgewater

    Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology

  • Performance of the EuroSCORE Models in Emergency Cardiac Surgery

    by Stuart W. Grant, Graeme L. Hickey, Ioannis Dimarakis, Graham Cooper, David P. Jenkins, Rakesh Uppal, Iain Buchan, Ben Bridgewater

    Background—: Accurate risk-adjustment models are useful for clinical decision making and are important for minimizing any tendency toward risk-averse clinical practice. In cardiac surgery, emergency patients are potentially at greatest risk of inappropriate risk-averse clinical decisions. UK cardiac surgery outcomes are currently risk-adjusted with EuroSCORE models. The objective of this study was to assess the performance of the EuroSCORE models in emergency cardiac surgery. Methods and Results—: The National Institute for Cardiovascular Outcomes Research database was used to identify adult cardiac surgery procedures performed in the United Kingdom between April 2008 and March 2011. A subset of procedures (July 2010–March 2011) was used for EuroSCORE II validation. The outcome measure was in-hospital mortality. Model calibration (Hosmer–Lemeshow test, calibration plots, calculation of calibration intercept and slope) and discrimination (area under receiver-operating characteristic curve [area under the curve]) were assessed. In total, 109 988 cardiac procedures at 41 hospitals were included, of which 3342 were defined as emergency procedures. Compared with performance in all cardiac surgery and nonemergency cardiac surgery, the logistic EuroSCORE and EuroSCORE II models had poorer discrimination (area under the curve, 0.703 and 0.690, respectively) and poorer calibration for emergency surgery. The EuroSCORE risk factors of female sex, chronic pulmonary disease, neurological disease, active endocarditis, unstable angina, recent myocardial infarction, and pulmonary hypertension were not identified as important risk factors for emergency cardiac surgery. Conclusions—: Both EuroSCORE models demonstrated poor calibration and comparatively poor discrimination for emergency cardiac surgery. This has important implications when these models are used for clinical decision making or to adjust governance analyses.


  • Publishing cardiac surgery mortality rates: lessons for other specialties

    by Ben Bridgewater, Graeme L Hickey, Graham Cooper, John Deanfield, James Roxburgh

    The Society for Cardiothoracic Surgeons in Great Britain and Ireland has been reporting outcome data for named surgeons since 2005. Ben Bridgewater and colleagues discuss their experiences and the implications for other specialties


  • Open Access

    Clinical registries: governance, management, analysis and applications

    by Graeme L. Hickey, Stuart W. Grant, Rebecca Cosgriff, Ioannis Dimarakis, Domenico Pagano, Arie P. Kappetein, B. Ben Bridgewater

    Clinical registries will have an increasingly important role to play in health-care, with a number already established in cardiac surgery. This review covers the fundamentals of establishing and managing clinical registries, including legal and ethical frameworks along with intellectual property attribution. Also discussed are important issues relating to the processing of data, data extraction and conducting analyses using registry data.


    • 24 January 2013
      • Vol. 54  (1) , 5-14

    Almanac 2012 adult cardiac surgery: the National Society Journals present selected research that has driven recent advances in clinical cardiology.

    by Ben Bridgewater

    This review covers the important publications in adult cardiac surgery in the last few years, including the current evidence base for surgical revascularisation and the use of off-pump surgery, bilateral internal mammary arteries and endoscopic vein harvesting. The changes in conventional aortic valve surgery are described alongside the outcomes of clinical trials and registries for transcatheter aortic valve implantation, and the introduction of less invasive and novel approaches to conventional aortic valve replacement surgery. Surgery for mitral valve disease is also considered, with particular reference to surgery for asymptomatic degenerative mitral regurgitation.